Cite
MLA Citation
Janev Fehmi et al.. “IgG1 pan-neurofascin antibodies define a severe and frequently fatal GBS-like neuropathy which responds to rituximab.” Journal of neurology, neurosurgery and psychiatry, vol. 93, no. 6, 2022, p. A1. http://access.bl.uk/ark:/81055/vdc_100158620343.0x00005b